Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.

Magnè, Federica; Cellerino, Maria; Balletto, Elisa; Aluan, Kenda; Inglese, Matilde; Mikulska, Malgorzata; Bassetti, Matteo

Magnè, Federica; Cellerino, Maria; Balletto, Elisa; Aluan, Kenda; Inglese, Matilde; Mikulska, Malgorzata; Bassetti, Matteo.

Magnè F; Infectious Disease Clinic, Policlinico San Martino IRCCS, Genoa, Italy.
Cellerino M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Balletto E; Infectious Disease Clinic, Policlinico San Martino IRCCS, Genoa, Italy.
Aluan K; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Inglese M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Mikulska M; Department of Neurology, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
Bassetti M; Infectious Disease Clinic, Policlinico San Martino IRCCS, Genoa, Italy.

Mult Scler ; : 13524585221103787, 2022 Jun 28.

Article in English | MEDLINE | ID: covidwho-2270307

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Mult Scler Journal subject: Neurology Year: 2022 Document Type: Article Affiliation country: 13524585221103787

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google